• NIH Launches Native Collective Research Effort Focused on Overdose

    Clinical Research News | Last week, the National Institutes of Health (NIH) has launched the Native Collective Research Effort to Enhance Wellness (N CREW) Program, an effort support Native American communities to lead public health research to address overdose, substance use, and pain, including related factors such as mental health and wellness. The planned program funding totals approximately $268 million over seven years.

    Aug 20, 2024

  • PCORI Announces $165 Million In Funding For New Health Research

    Clinical Research News | The Patient-Centered Outcomes Research Institute (PCORI) has approved funding awards totaling more than $165 million for new patient-centered comparative clinical effectiveness research (CER), as well as research to improve methods and strengthen the science of engagement in patient-centered CER.

    Aug 15, 2024

  • First Clinical Trial of ‘Paradoxical Intervention’ for Cancer to Begin Soon

    Clinical Research News | Cancer cells are “not like superheroes that have no vulnerabilities.” Most current therapies try to block the signaling to prevent cancer’s uncontrolled division, but inevitably tumor cells resist the blockage and become far less responsive to subsequent therapy.

    Aug 14, 2024

  • Follow Five Best-in-Class Technology Practices for Improved Data Management Outcomes

    Clinical Research News | In today's data-driven world, clinical trials rely heavily on effective data management to ensure the accuracy and integrity of research findings. Improved data management outcomes ultimately benefit the primary beneficiary—the patient.

    Aug 13, 2024

  • Policy Change Alone Won’t Achieve Equity in Clinical Trial Participation

    Clinical Research News | A federal mandate that all state Medicaid programs cover the routine costs of participation in clinical trials could have a “meaningful impact” on equity in study participation. The focus should now be on ensuring states collaborate with frontline clinicians to ensure they are aware of the latest Medicaid policy change, and that those who “disproportionately treat patients from minoritized communities are plugged into relevant trial networks and able to refer patients to [applicable] trials.”

    Aug 8, 2024

  • Safe and Intriguing ‘Nature’s Drugs’ Taking on Complex Diseases

    Clinical Research News | The cost of bringing a drug to market has, by some estimates, ballooned to $3 billion and the central problem could be the “misapplication of technology.” Since completion of the Human Genome Project, the focus had shifted heavily toward orphan drugs with a single genetic target, suitable only to highly targeted genetic technology platforms.

    Aug 6, 2024

  • Leveraging Advanced Technologies for Clinical Trial Success

    Clinical Research News | Clinical trials are a crucial step to advancing healthcare and bringing new treatments to patients. However, drug development is a lengthy, expensive, and high-risk proposition, and, according to PhRMA, a process that can take up to 15 years with an average cost exceeding $2 billion per new medicine.

    Aug 2, 2024

  • Trials ‘Still Largely White and Largely Male’ Due to Hidden Biases

    Clinical Research News | Randomized clinical trials (RCTs) may need some serious revamping, based on mounting evidence of systemic biases afflicting the entire enterprise. Despite decades of efforts to realize equitable participation by marginalized groups, notably women and people of color, RCTs are “still largely white and largely male.”

    Jul 31, 2024